Design and development of new class of Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors
Mycobacterium tuberculosis L-alanine dehydrogenase (MTB L-AlaDH) is one of the important drug targets for treating latent/persistent tuberculosis. In this study we used crystal structure of the MTB L-AlaDH bound with cofactor NAD+as a structura